myCAFs Were Correlated With Tumor Metabolic Features, Senescence-Associated Secreting Phenotype, and Cancer Stemness, Influencing the Responsiveness of BLCA Patients to Chemotherapy. The gene discussed is SCGN; the disease is bladder transitional cell carcinoma.